Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $251.02M in the twelve months ending March 31, 2024, with 73.58% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.00M, a -20.70% decrease year-over-year. In the year 2023, Axsome Therapeutics had annual revenue of $270.60M with 440.80% growth.

• Revenue (ttm): $251.02M
• Revenue Growth: +73.58%
• P/S Ratio: 14.93
• Revenue / Employee: $460,593
• Employees: 545
• Market Cap: 3.75B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.60M	220.56M	440.80%
Dec 31, 2022	50.04M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.